Comparison of Dual-Task Timed Up and Go Test (Cognitive) and 3-m Backwards Walk Test

January 23, 2022 updated by: Emel Taşvuran Horata, Afyonkarahisar Health Sciences University

Psychometric Evaluation of Dual-Task Timed Get Up and Go Test (Cognitive) and 3-m Backwards Back Test in Community-dwelling Stroke Individuals

Two balance assessment tools that have been used recently have attracted considerable attention: the Dual-Task Timed Up and Go Test (cognitive) (DTUG) and the 3-m Backward Walk Test (3MBWT). The aim of this study is to compare the psychometric properties of two clinically proven balance assessment tools.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

There are unidimensional and multidimensional scales used to evaluate gait balance after stroke. Unidimensional scales (DTUG, 3MBWT) can be useful in clinical practice and in screening for basic balance problems. Two balance assessment tools that have been used recently have attracted considerable attention: the Dual-Task Timed Up and Go Test (cognitive) (DTUG) and the 3-m Backward Walk Test (3MBWT). The aim of this study is to compare the psychometric properties of two clinically proven balance assessment tools. In the study, construct validity, concurrent validity, reliability, and cut-off score (for determining falling risk) of the two tests will be calculated.

Study Type

Observational

Enrollment (Anticipated)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey
      • Afyonkarahisar, Turkey, 03030
        • Recruiting
        • Afyonkarahisar Health Science University
        • Contact:
        • Principal Investigator:
          • EMEL TAŞVURAN HORATA, PhD
        • Sub-Investigator:
          • Fatma EKEN, MSc
        • Sub-Investigator:
          • Hilal YEŞİL, PhD
        • Sub-Investigator:
          • SEVDA ADAR, MD
        • Sub-Investigator:
          • Ümit DÜNDAR, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All of the participants will consist of stroke individuals who receive inpatient or outpatient treatment in the Physical Therapy and Rehabilitation Polyclinic. All assessments will be done face to face. Men and women aged 50-85 years who have had a stroke for at least 6 months will be included in the study.

Description

Inclusion Criteria:

  • Single stroke with unilateral hemiparesis at least 6 months prior to the study,
  • Be in the age range of 50-85 years
  • Able to walk at least 10 meters independently with or without a walking aid,
  • Getting at least 24 points from the Standardized Mini-Mental Test
  • It is to be able to follow two-stage commands and perform subtraction.

Exclusion Criteria:

  • Presence of additional orthopedic or neurological diseases that may affect balance and walking,
  • Having uncorrected vision and hearing problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dual-Task Timed Up and Go Test (cognitive)
Time Frame: 5 minutes
It evaluates balance and functional mobility with a simultaneous cognitive and motor task. The cognitive task of the test is 3-series subtraction, while the TUG test is the motor task. Performance is recorded in seconds.
5 minutes
3-m Backward Walk Test
Time Frame: 5 minutes
It is used to assess fall risk and balance. It is calculated in how many seconds an individual can walk backwards a marked distance of 3 meters.
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Afyonkarahisar Health Sciences University

Investigators

  • Principal Investigator: EMEL TAŞVURAN HORATA, PhD, AFSU

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2022

Primary Completion (Anticipated)

January 2, 2023

Study Completion (Anticipated)

January 2, 2024

Study Registration Dates

First Submitted

January 23, 2022

First Submitted That Met QC Criteria

January 23, 2022

First Posted (Actual)

January 27, 2022

Study Record Updates

Last Update Posted (Actual)

January 27, 2022

Last Update Submitted That Met QC Criteria

January 23, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021/534

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Dual-Task Timed Up and Go Test (cognitive)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe